Abstract
BACKGROUND. Patients who suffer from primary headache report frequently several anxiety symptoms. However, these symptoms have not been investigated yet among Colombian patients with migraine.
OBJECTIVE. To determine the prevalence of anxiety symptoms in patients with primary headache.
METHOD. Patients over eighteen year-old with primary headaches were evaluated. We excluded patients with mental disorder history and pregnant women. Anxiety symptoms were measured with Zung’s self report scale for anxiety.
RESULTS. We included 223 patients. The mean age was 37,0 years (SD 13.0); 82,5% were female, the average scholarity was 8,5 years; 63,2% were married; 56,1% had migraine, 43,5% tension-type headache and 0,4% cluster headache. The average score for anxiety was 52,9 (SD 8.8). Clinically significant anxiety symptoms were found in 62,8%. Scores and the prevalence of anxiety symptoms were significantly higher for women than men; but were independent of age, educational level, marital status, and headache type.
We conclude that the prevalence of anxiety symptoms is high in patients with primary headache.
References
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988; 8 (Suppl 7): 1-96.
Henry P, Auray JP, Gaudin AF, Dartigues JF, Duru G, Lantéri-Minet M, et al. Prevalence and clinical characteristics of migraine in France. Neurology 2002; 59: 232-7.
Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267: 64-7.
Rasmussen BK, Jensen R, Schroll M, Olsen J. Epidemiology of headache in population: a prevalence study. J Clin Epidemiology 1993; 12: 174-94.
Pradilla G, Vesga BE, Leon-Sarmiento FE, Bautista LE, Núñez LC, Vesga E, et al. Neuroepidemiología en el oriente colombiano. Rev Neurol 2002; 34: 1035-43.
Morillo LE, Alarcón F, Aragana N, Aulet S, Chapman A, Conterno L, et al. Prevalence of migraine in Latin America. Headache 2005; 45: 106-17.
Kessler RC, McGonagle KA, Zhao S, Nelson CB,Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
Torres Y, Posada JA. Estudio Nacional de Salud mental y consumo de sustancias psicoactivas, Colombia, 1993. Santafé de Bogotá. Ministerio de Salud; 1995.
Aromaa M, Sillanpaa M, Rautava P, Helenius H. Prevalence of frequent headache in young finish adults starting a family. Cephalalgia 1993; 13: 330-7.
Ham LP, Andraski F, Packard RC, Bundrick CM. Psychopathology in individuals with post-traumatic headaches and other pain types. Cephalalgia 1994; 14: 118-26.
Ficek SK, Wittrock DA. Subjective stress and coping in recurrent tension-type headache. Headache 1995; 35: 455-60.
Kowacs F, Socal MP, Ziomkowski SC, Borges-Neto VF, Toniolo DP, Francesconi CRM, et al. Symptoms of depression and anxiety, and screening for mental disorders in migrainous patients. Cephalalgia 2003; 23: 79-89.
Zwart JA, Dyb G, Hagen K, Odegard KJ, Dahl AA, Bovim DG, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003, 10: 147-52.
Devlen J. Anxiety y depression in migraine. J R Soc Med 1994; 87: 338-41.
Breslau N, Davis G. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia 1992; 12: 85-90.
Merikangas KR, Angst J, Isler H. Migraine and Psychopathology. Result of the Zurich Cohort study of young adults. Arch Gen Psychiatry 1990; 47: 849-53.
Lipton RB, Newman LC. Epidemiology, impact, and comorbidities of migraine headaches in the United States. Neurology 2003; 60 (Suppl 2): S3-S8.
Breslau N, Rasmussen BK. The impact of migraine. Epidemiology, risk factors, and co-morbidities. Neurology 2001, 56 (Suppl 1): S4-S12.
Zung WW. A rating instrument for anxiety disorders.
Psychosomatics 1971; 12: 371-9.
Gilbody SM, House AO, Sheldon TA. Routinely administered questionnaires for depression and anxiety: systematic review. BMJ 2001; 322: 406-9.
Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika 1951; 16: 297-334.
Dean J, Dean DA, Coloumbier D, Brebdel KA, Smith DC, Burton AH, Dicker RC, et al. Epi Info 6.04c. A word processing, database, and statistic program for public health. Center for Disease Control and Prevention (Atlanta, USA), and World Health Organization (Geneva, Switzerland), 1997.
Sheftell FD, Atlas SJ. Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache 2002; 42: 934-44.
Silberstein SD. Shared mechanisms and comorbidities in neurological and psychiatric disorders. Headache 2001; 41 (Suppl 1): S11-S17.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity. Arch Intern Med 2003; 163: 2433-45.
Hudson JI, Mangweth B, Pope HG, De Col C, Hausmann A, Gutweniger S, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003; 60: 170-7.
Hudson JI, Pope HG Jr. Affective spectrum disorder: Does antidepressant response identify a family disorders with a common pathophysiology? Am J Psychiatry 1990; 147: 152-64.
Guidetti V, Galli F, Fabrizi P, Giannantoni AS, Napoli L, Bruni O, et al. Headache and psychiatry comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998; 18: 455-62.
Morillo LE, Alarcón F, Aragana N, Aulet S, Chapman A, Conterno L, et al. Clinical characteristics and pattern of medicament use of migraineurs in Latin America from 12 cities of 6 countries. Headache 2005; 45: 118-26.
Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2005; 23: 165-78.
Torelli P, Lambru G, Manzoni GC. Psychiatric comorbidity and headache: clinical and therapeutical aspects. Neurol Sci 2006; 27 (Suppl 2): S73-S6.
Merikangas KR. Association between psycho- pathology and headache syndromes. Cur Op Neurol 1995; 8: 248-51.
Campo-Arias A. Antidepresivos en la profilaxis de migraña: una aproximación. Rev Neurol 2004; 38: 864-8.
Rapoport AM, Bigal ME. Migraine preventive therapy: current and emerging treatment options. Neurol Sci 2005; 26: S111-S20.
Savarese M, Guazzelli M, Prudenzano MP, Carnicelli M, Rossi M, Cardinali V, et al. Tertiary treatment for psychiatric comorbidity in headache patients. J Headache Pain 2005; 6: 231-3.
Lake AE. 3erd. Behavioral and nonpharmacologic treatments of headache. Med Clin North Am 2001; 85: 1055-75.
Organización Mundial de la Salud. Clasificación Internacional de las Enfermedades (CIE). Trastornos mentales y del comportamiento. Criterios diagnósticos de investigación. 10 Edición. Madrid, Meditor 1993.
American Psychiatry Association. Diagnostic and statistical manual for mental disorder. Fourth Edition. Washington, DC, American Psychiatry Association, 1994.
Sánchez R, Gómez C. Conceptos básicos sobre la validación de escalas. Rev Colomb Psiquiatr 1998; 27: 121-30.
Oviedo HC, Campo-Arias A. Aproximación al uso del coeficiente alfa de Cronbach. Rev Colomb Psiquiatr 2005; 34: 572-80.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.